tiprankstipranks
4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
US Market

4D Molecular Therapeutics (FDMT) Cash flow

Compare
351 Followers

4D Molecular Therapeutics Cash Flow

FDMT's free cash flow for Q4 2024 was $-46.81M. For the 2024 fiscal year, FDMT's free cash flow was decreased by $-56.02M and operating cash flow was $-45.86M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -134.59M$ -75.79M$ -86.69M$ -69.13M$ -50.91M
Investing Cash Flow
$ -302.44M$ 115.72M$ -17.05M$ -172.68M$ -1.00M
Financing Cash Flow
$ 337.25M$ 156.83M$ 3.08M$ 118.09M$ 278.98M
End Cash Position
$ 149.34M$ 249.11M$ 52.35M$ 153.00M$ 276.73M
Free Cash Flow
$ -134.59M$ -78.56M$ -98.22M$ -78.24M$ -51.91M
Currency in USD

4D Molecular Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis